Related Experiment Videos
[Macro-CK type 1: a methodological study approach and its clinical significance].
E Soffritti1, R Ferrari, R Bernardoni
1Laboratorio di analisi cliniche, U.S.L. 34, Copparo, Ferrara.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|December 1, 1986
Summary
This study introduces an analytical method to identify atypical creatine kinase (CK) carriers, preventing misdiagnosis of elevated CK-MB levels. The procedure is crucial for accurate cardiac pathology assessment in specific patient cases.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Immunology
Context:
- Elevated creatine kinase-MB (CK-MB) levels are critical indicators in diagnosing cardiac conditions.
- Immune inhibition assays are commonly used for CK-MB quantification.
- Atypical creatine kinase (CK) carriers can lead to falsely elevated CK-MB measurements.
Purpose:
- To describe an analytical procedure for identifying atypical CK carriers.
- To differentiate true CK-MB elevations from those caused by immune interference.
- To ensure accurate diagnosis in patients with suspected cardiac pathology.
Summary:
- An analytical procedure was developed to detect atypical creatine kinase (CK) carriers who exhibit falsely elevated CK-MB levels due to immune inhibition.
- The method was successfully applied to two patient samples: one with neoplastic pathology and another with cardiac pathology, both exhibiting immune-mediated CK discrepancies.
- The findings highlight the necessity of systematically measuring the "real" MB isoenzyme in cases with significantly elevated CK-MB activity.
Impact:
- Improves diagnostic accuracy for cardiac conditions by distinguishing true CK-MB elevations from artifacts.
- Prevents misdiagnosis and inappropriate patient management stemming from false-positive CK-MB results.
- Provides a reliable method for clinical laboratories to address challenges posed by atypical CK carriers.